Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QLB vs Intrathecal Morphine for Post-Cesarean Analgesia
NCT06612424Completed
- Sponsor
- Gaziosmanpaşa Training and Research Hospital
- Start
- Sep 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of morphine and bupivacaine in postoperative pain (3 arms), sponsored by Gaziosmanpaşa Training and Research Hospital. Primary endpoint: Total analgesic use at 24 hours. Started Sep 2024; status: completed.
02
Drugs
morphinebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06612424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06612424.